Concepedia

Brent Douty

BD

Statistics

Publications

15

Citations

1.2K

H-Index

13

Active since

1993

Affiliations

Incyte (United States)(Current)

Experimental Station

Sterling Research Group

Sterling Research Group (United States)

Brent Douty is an author at Incyte (United States) specializing in pharmacology, medicinal chemistry, and drug design.

Publications per year

1993–2020

15

Publications

15

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

Eddy W. Yue, Richard Sparks, Padmaja Polam et al. · ACS Medicinal Chemistry Letters · 2017 · 296 citations · Full text

, , +8

Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model

Eddy W. Yue, Brent Douty, Brian Wayland et al. · Journal of Medicinal Chemistry · 2009 · 217 citations · Full text

, , +9

Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics

Andrew P. Combs, Eddy W. Yue, Michael J. Bower et al. · Journal of Medicinal Chemistry · 2005 · 102 citations · Full text

, , +16

Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor

Joseph M. Salvino, Peter R. Seoane, Brent Douty et al. · Journal of Medicinal Chemistry · 1993 · 97 citations · Full text

, , +9

The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.

David G. Sawutz, Joseph M. Salvino, Roland E. Dolle et al. · Proceedings of the National Academy of Sciences · 1994 · 89 citations

, , +12

1–5 of 15